Then, we selected 160 samples and compared the expression of HE4 with ProGRP, Cyfra21‐1, NSE, SCC, and CEA in the three groups of people, confirming that HE4 has the characteristics of characterizing lung cancer. This evidence concerns the gene SERPINB3 and lung cancer.